StocktoriaLifeward Ltd. LFWD
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
4/9
Piotroski F — financial health
-44.62
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $22.0M | $25.7M | $13.9M | $5.5M | $6.0M |
| Gross profit | $8.4M | $8.2M | $4.5M | $1.9M | $2.9M |
| Operating income | -$19.7M | -$29.3M | -$23.6M | -$19.1M | -$12.7M |
| Net income | -$19.9M | -$28.9M | -$22.1M | -$19.6M | -$12.7M |
| Operating cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Free cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M |
| Total assets | $22.9M | $30.5M | $63.2M | $74.2M | $94.8M |
| Total liabilities | $14.5M | $11.6M | $16.7M | $6.1M | $5.4M |
| Shareholders' equity | $8.4M | $18.8M | $46.5M | $68.2M | $89.4M |
| Ratios | |||||
| Gross margin | 38.2% | 32.0% | 32.1% | 34.6% | 48.7% |
| Operating margin | -89.3% | -114.4% | -170.4% | -346.6% | -212.1% |
| Net margin | -90.4% | -112.8% | -159.8% | -355.1% | -213.5% |
| FCF margin | -76.4% | -84.6% | -149.8% | -325.1% | -193.0% |
| Return on assets | -87.0% | -94.9% | -35.0% | -26.4% | -13.4% |
| Return on equity | -236.8% | -153.5% | -47.6% | -28.7% | -14.2% |
| Current ratio | 1.31 | 2.08 | 3.33 | 15.16 | 22.91 |
| Revenue growth | -14.1% | 85.2% | 151.4% | -7.6% | 35.8% |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -44.62 (distress)
- Working capital / assets 0.165
- Retained earnings / assets -12.434
- EBIT / assets -0.859
- Equity / liabilities 0.58
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001607962 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.